Share Name Share Symbol Market Type Share ISIN Share Description
Polarean Imaging Plc LSE:POLX London Ordinary Share GB00BF3DT583 ORD GBP0.00037
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 22.50p 21.00p 24.00p 22.50p 22.50p 22.50p 24,145 01:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 0.0 0.0 - 26

Polarean Imaging Share Discussion Threads

Showing 126 to 149 of 150 messages
Chat Pages: 6  5  4  3  2  1
DateSubjectAuthorDiscuss
14/10/2019
23:37
Name me a share that doesn't have any sellers? :) People will take profits at different levels, value will always prevail. Successful phase III trial should result in a very different value here.
aimsurfer
14/10/2019
21:28
10 k seller still dumping their 13p shares.
john henry
14/10/2019
14:21
Good to see buyers still accumulating. News must be any day now.Public holiday in the states today, wonder if last patients were pencilled in for today when they are potentially not in work.Either way last indication was the trials should complete this week.
aimsurfer
12/10/2019
16:28
#POLX Polarean Imaging. Jonathan Allis (NED) bought 1.54m shares at 13.06 pence. Amphion overhang now cleared. Great to see a material director purchase of £200,000. Jonathan was founder and CEO of #Blueearthdiagnostics - startup medical imaging company sold in 2019 for $450m
loglorry1
12/10/2019
06:25
Discussed on the Vox Markets podcast yesterday: hTTps://audioboom.com/posts/7393419-vadim-alexandre-discusses-beximco-pharmaceuticals-and-polarean-imaging
mcfly79
11/10/2019
19:54
Would have cost him around £200k. Got a good price but it's still its not small change.
aimsurfer
11/10/2019
16:33
Nice directors purchase, he definitely isn't the one selling them currently!
slicethepie
11/10/2019
11:06
One of the buyer who got in at 13p made some noise on twitter before the trades started going through. He was trying to convince Justin that amp were out, conversation then moved offline. Some might take profits but hopefully some will also hold for the big news and gains. This should see multiples with FDA approval for those willing to wait.
aimsurfer
11/10/2019
11:03
i make that 28 10k sells so far. Talk about making it obvious LOL
john henry
11/10/2019
09:45
How would Justin know? Sounds BS to me.
jaknife
11/10/2019
08:40
Hopefully cleared soon.
mcfly79
11/10/2019
08:38
I think it will be some of the buyers flipping. Comment by Justin on twitter that some took more than needed to get the deal done.
mcfly79
11/10/2019
08:34
That will be the mm, very unlikely to be other recipients as they will (should be) long term supporters and not after a quick buck!
slicethepie
11/10/2019
08:05
There has been a constant 10K seller since the 8th so im guessing these are a buyer of the 13p shares selling. 24 so far.
john henry
11/10/2019
07:56
Great to get confirmation. This will be the first time some people hear about it.Amphion are surely bust now. The $2.3m loan was just part of much larger debts. They had $30m in total.
mcfly79
11/10/2019
07:49
Onwards and upwards
hamidahamida
11/10/2019
07:48
It will be interesting to see who else took this stake, I assume the mm took a chunk and is still supplying the market demand however there must be more Tr1 given size of sale.
slicethepie
11/10/2019
07:08
There we have it. No more significant immediate selling pressure. Good news ahead of trial results.
aimsurfer
11/10/2019
02:36
Amphion was delisted from AIM some time ago due to a failure to communicate their accounts on time as per AIM rules so this wouldn’t be the first time they’ve shafted themselves. 13p per share also demonstrates that the amended lender terms AMP apparently negotiated for a further 12 months meant FA to the lender. Who sells at a 50% discount to the market price? both parties were clowns in my humble opinion. This stock is going up short term (TN1 and trial completion), mid (trial readouts) and long term (FDA approval?) I can’t see any merit in the risk this will fail. Only thing that could prevent this stock sailing well into profit is the corruption of USA politics and institutions, not impossible of course, arguably all-ready present. The FDA will need a lot of legal ammunition to prevent this being approved so I will trade this in the short term and hold for the long term. Good luck to all holders. A juicy week upon us. My prediction is 25p+ within 14 days. 29p by December readouts and 32p by March. X C
travelhead
10/10/2019
23:53
More likely Amphion will turn into a shell company likely Motif as pretty sure disposal cleared their debt.
pejaten
10/10/2019
23:24
Amphion lost all their shares in Polarean and are facing almost certain bankruptcy/ delisting. I'm guessing they have more important things to worry about than notifying that their lender decided to sell all their polx shares on the cheap.
aimsurfer
10/10/2019
17:25
I'm surprised we haven't had an announcement from Polarean or Amphion.On Justin's video posted last night he says he's been told that a group of UK investors did a deal with the lender to buy the shares at 13p:https://youtu.be/A-QORFYnadMSee from 16m20s.
mcfly79
09/10/2019
21:11
global - watch the link from about 11 mins for a better explanation of revenue https://www.youtube.com/watch?v=mkHhSgK2S1s
wooster4
09/10/2019
20:55
yes - that will be the main revenue stream.
wooster4
Chat Pages: 6  5  4  3  2  1
Your Recent History
LSE
POLX
Polarean I..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191016 11:41:13